Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR

CONCLUSIONS: Our findings highlight the potential of DOXA as a therapeutic option for metastatic TNBC, warranting further investigation.PMID:37924112 | PMC:PMC10625208 | DOI:10.1186/s13046-023-02866-z

Source: Clinical Genitourinary Cancer - November 4, 2023 Category: Cancer & Oncology Authors: Seongjae Kim Jung Min Park Soeun Park Eunsun Jung Dongmi Ko Minsu Park Juyeon Seo Kee Dal Nam Yong Koo Kang Kyoungmin Lee Lee Farrand Yoon-Jae Kim Ji Young Kim Jae Hong Seo Source Type: research